FLEMINGTON, N.J., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced that Dr. Alex Zukiwski, Chief Executive Officer and Mr. Lawrence Kenyon, Chief Financial Officer, are scheduled to present at the 16th Annual Rodman & Renshaw Global Investment conference being held September 8-10, 2014 in New York and the Aegis Capital 2014 Healthcare & Technology Conference being held September 10-13, 2014 in Las Vegas.
Details of the presentations are as follows:
|Conference:||Rodman & Renshaw Global Investment Conference|
|Date:||Tuesday, September 9, 2014|
|Time:||3:45 p.m. EDT|
|Conference:||Aegis Capital 2014 Healthcare & Technology Conference|
|Date:||Thursday, September 11, 2014|
|Time:||11:25 a.m. PDT|
Investors attending the conferences who would like to schedule a 1-on-1 meeting with Arno management may do so by contacting their Rodman & Renshaw or Aegis Capital representatives, or Lee Roth of The Ruth Group at firstname.lastname@example.org.
About Arno Therapeutics
Arno Therapeutics is a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer. Arno has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates. These compounds are in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors. For more information about the company, please visit www.arnothera.com.
CONTACT: The Ruth Group Lee Roth (investors) email@example.com (646) 536-7012 Kirsten Thomas (media) firstname.lastname@example.org (646) 536-7014 Arno Therapeutics Lawrence Kenyon email@example.com (862) 703-7171
Source:Arno Therapeutics Inc.